Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Adenosine A[sub]2A[/sub] Receptor Availability in Parkinson[apos]s Disease Patients with and without Levodopa Induced Dyskinesias Studied with [[sup]11[/sup]C]SCH442416 PET
Movement Disorders
(-)
002
Authors/Disclosures
Anil F. Ramlackhansingh, MD No disclosure on file
Osigwe P. Agabi, MD (lagos university teaching hospital) No disclosure on file
No disclosure on file
Sheikh I. Ahmed, MD (Zazolimited) No disclosure on file
No disclosure on file
No disclosure on file
Nicola Pavese, MD (Newcastle University) Dr. Pavese has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Pavese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial. Dr. Pavese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Pavese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Britannia. The institution of Dr. Pavese has received research support from Multiple System Atrophy Trust. The institution of Dr. Pavese has received research support from Parkinson's UK. The institution of Dr. Pavese has received research support from Independent Research Fund Denmark. The institution of Dr. Pavese has received research support from European Union. The institution of Dr. Pavese has received research support from MRC.
David J. Brooks, MD, DSc, FRCP (Imperial College London) No disclosure on file